-
Public can now ascertain the quality of drugs by checking out the QR code on the product packaging itself
-
During the course of the raids conducted in March, 2024, the DCA seized stocks of medicines worth Rs 3.03 lakh
-
The genuineness of the drug licenses can be verified through the Third Party Verification system, which is available on the DCA website, the advisory said
-
DCA officers detected unauthorised stocking of drugs, including IV fluids, in violation of the provisions of Schedule K of the Drugs Rules, 1945 and also found certain drugs were sold by the hospital at prices higher than the MRP
-
The MRP rates on the drug indicated were significantly higher than the ceiling price fixed for the product under the Drugs (Prices Control) Order, 2013 by National Pharmaceutical Pricing Authority (c), the price control regulatory authority
-
The Calcium with Vitamin D3 tablets were falsely manufactured and sold under the guise of ‘food products/nutraceuticals’
-
Itramen-200 Capsules had MRP of Rs 350 for 10 capsules, but ceiling price fixed by NPPA is Rs 221.2
-
The seizure was made for exporting the products manufactured by other pharmaceutical companies to Russia falsely under their own name and for unauthorized packing of antibiotics, DG, TSDCA, V B Kamalasan Reddy on Wednesday said
-
The DCA raided the premises of D Narsimha, Bijwar village, Utkoor mandal, Narayanpet district, and seized 41 varieties of drugs stocked illegally for sale.
-
While each of us should aim to be fit as a fiddle, how we achieve our fitness goals is the real question. With Ozempic and Wegovy becoming a global rage, here's what experts have to say about using semaglutides for weight loss
-
During the course of the raids, the TSDCA seized 23 varieties of medicines including antibiotics, analgesics etc worth Rs 18, 000 from the illegally run medical shop
-
In the month of September alone, the lab reported 14 Not of Standard Quality (NSQ) drugs, which include antibiotics, antiulcer drugs, anti-allergics and haematinics
-
Pregabalin is an approved drug in India used for management of diabetic neuropathy and fibromyalgia syndrome
-
The label of the product made a misleading claim by indicating that it can treat ‘spasmodic dysmenorrhea, menstrual disorders’.
-
The DCA seized stocks of Supralax Syrup (Sodium Picosulfate Oral Solution BP) manufactured by Shervotec Pharmaceuticals, Solan, Himachal Pradesh and marketed by MABO Pharmacls, Chennai from a medical shop at Karimnagar.
-
The DCA teams seized stocks of Cardinol Joshanda, a Unani medicine that claimed to clear heart blockages and Colinol-SPAS Tablets, an allopathic medicine, which claimed to treat disorders of menstrual flow.
-
During the course of the raids, the TSDCA seized substantial stocks of antibiotics, steroids, analgesics, anti-diabetics, anti-hypertensive etc. worth Rs 47, 000.